Trial Profile
Phase II Double Blind Dose Finding Trial of Bupropion Versus Placebo for Sexual Desire in Women With Breast or Gynecologic Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Mar 2022
Price :
$35
*
At a glance
- Drugs Bupropion (Primary)
- Indications Sexual function disorders
- Focus Therapeutic Use
- 27 May 2021 Status changed from active, no longer recruiting to completed.
- 27 Apr 2020 Status changed from recruiting to active, no longer recruiting.
- 14 Feb 2020 Planned primary completion date changed from 30 Oct 2019 to 30 Oct 2020.